International Review of Ophthalmology

Previous Articles     Next Articles

The research progression of atropine in myopia prevention and control

Li Weiran, Zhou Jibo   

  1. Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine. Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China
  • Received:2015-03-25 Online:2019-04-25 Published:2019-04-30
  • Contact: ZHOU Jibo, Email: zhoujibo1000@aliyun.com

Abstract:

It’s especially important to find an effective medicine for the prevention and control of myopia, since a rising tendency in the past few years. Atropine was known to be able to inhibit myopia progression. However, some side effects prevent atropine from popular clinical work. Recently, researchers find that low\|concentration atropine has much less side effect, compared with high\|concentration atropine, and has more sustained and durable effect without affecting the visual quality of patients. Additionally, combined the optical lenses with atropine eye drops can enhance the preventing effect, compared with using atropine eye drops alone.(Int Rev Ophthalmol, 2019, 43:  133-137)